383sek
0,0 %
Date:2026-01-27Time:17:29:41Latest report:Q2-2025List:First NorthTicker:NANEXA
Market Cap:600 msekEnterprise Value:597 msekNet Sales:14,3 msekEarnings:-37,6 msekEmployees:0ISIN:SE0007074166

Ratios

10-year key figure history for Nanexa turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Nanexa with index and moving average MA50 and MA200.

Stockprice:3,83
MA50:2,87
MA200:2,25
Price/MA200:67,5 %
RSI (14):61,5
Price/MA50:31,6 %

Description

Nanexa is a drug delivery company with a proprietary platform used for the formulation of injectable depot drugs that create a supply of drugs to the blood. The company's technology is based on encapsulating drug particles with a thin shell and creating opportunities for pharmaceutical companies to develop new products. Nanexa has collaborations with several pharmaceutical companies, mainly around the Nordic market.

Medical Equipment